Growth Metrics

BioLineRx (BLRX) Net Cash Flow (QoQ) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -835.64%
Sep 30, 2025 128.57%
Jun 30, 2025 -72.91%
Mar 31, 2025 -191.66%
Dec 31, 2024 265.67%
Sep 30, 2024 -122.23%
Jun 30, 2024 131.89%
Mar 31, 2024 145.96%
Dec 31, 2023 -58.96%
Sep 30, 2023 -279.52%
Jun 30, 2023 190.23%
Mar 31, 2023 42.34%
Dec 31, 2022 -174.22%
Sep 30, 2022 -129.48%
Jun 30, 2022 306.14%
Mar 31, 2022 -11.27%
Dec 31, 2021 60.83%
Sep 30, 2021 -368.83%
Jun 30, 2021 316.81%
Mar 31, 2021 -105.80%
Dec 31, 2020 883.19%
Sep 30, 2020 151.35%
Jun 30, 2020 354.38%
Mar 31, 2020 -145.33%
Dec 31, 2019 446.08%
Sep 30, 2019 -118.48%
Jun 30, 2019 -43.79%
Mar 31, 2019 175.31%
Dec 31, 2018 -69.79%
Sep 30, 2018 64.20%
Jun 30, 2018 -180.13%
Mar 31, 2018 254.74%
Dec 31, 2017 -435.60%
Sep 30, 2017 -106.99%
Jun 30, 2017 1,376.52%
Mar 31, 2017 76.43%
Dec 31, 2016 -1,390.76%
Sep 30, 2016 115.85%
Jun 30, 2016 21.61%
Mar 31, 2016 -1,021.15%
Dec 31, 2015 102.59%
Sep 30, 2015 -407.28%
Jun 30, 2015 -43.80%
Mar 31, 2015 103.51%
Dec 31, 2014 133.62%
Sep 30, 2014 -350.13%
Jun 30, 2014 -562.58%
Mar 31, 2014 105.16%
Dec 31, 2013 -64.38%
Sep 30, 2013 -281.47%
Jun 30, 2013 118.40%